Archived Announcements 2005


12/12/2005
FerriScan Gains Independent Validation

29/11/2005
Appendix 3B

29/11/2005
Change of Director's Interest Notice

15/11/2005
Close of SPP & Appointment of US Corporate Advisor

14/11/2005
Results of AGM

14/11/2005
AGM Presentation

3/11/2005
Expands Into Fibrosis Field

31/10/2005
Commitments Test Entity - First Quarter Results

25/10/2005
Shareholder Letter

21/10/2005
Notice Under Section 708A

21/10/2005
Appendix 3B

14/10/2005
Annual Report/Notice of AGM

12/10/2005
First European Patent Granted

10/10/2005
Share Purchase Plan

6/10/2005
Notice Under Section 708A

4/10/2005
Awarded WA State Government Health Supply Contract

30/09/2005
Annual Report

29/9/2005
$1m Placement & Share Purchase Plan

28/9/2005
Trading Halt

22/9/2005
Results of Meeting

22/09/2005
General Meeting Presentation

13/9/05
Appendix 4E Preliminary Final Report

13/9/05
Resonance Signs MOU with Major US Radiology Chain


22/8/05
Notice of AGM

16/8/05
Agreement with US Research Institute

5/8/05
To Provide Expanded FerriScan Service to Pharamceutical Company

29/7/05
Appendix 4C Quarterly Report 30 June 2005

6/7/05
Notice of Initial Substantial Shareholder

6/7/05
Expansion of Medical Advisory Board

6/7/05
Investor Update

30/6/05
Appendix 3B New Issue of Securities

30/06/05
Notice of Initial Substantial Shareholder

22/06/05
Appendix 3X Initial Directors Notice - J Ives

22/06/05
Appendix 3X Initial Directors Notice - I Anderson

16/06/05
Notice Under Section 708(A)

15/06/05
Appendix 3X Initial Directors Notice - J Williams

14/06/05
Form 603 Substantial Shareholder Notice

10/06/05
Placement to Fund Australian FerriScan

10/06/05
Revised Appendix 3B

8/06/05
New Issue of Securities

31/05/05
Investor Update

31/05/05
Results of General Meeting

27/4/05
Notice of General Meeting

27/4/05
Appendix 4C Quarterly Report 31 March 2005

8/04/05
April Investor Update

24/03/05
Resonance Group and DCA Group to Cooperate on Commercial Launch of FerriScan Test

1/03/05
Resonance Health Offers to Acquire Remaining 100% of IVB - Subject to Shareholder Approval

1/03/05
Trading Halt

28/02/05
Half Year Financial Report 31 December 2004

1/02/05
Investor Presentation

1/02/05
Appendix 3B Issue and Conversion of Securities

31/01/05
Appendix 4C Quarterly Report

28/01/05
FDA Approves FerriScan

6/01/05
Results of General Meeting

 

 

Privacy  |  Disclaimer
© Copyright Resonance Health Ltd | © Copyright Resonance Health Analysis Services